Peter Sordillo
Technik-/Wissenschafts-/F&E-Leiter bei SignPath Pharma, Inc.
Profil
Peter Sordillo is currently the Chief Medical Officer, Chief Science Officer & VP at SignPath Pharma, Inc. and an Associate Professor at Icahn School of Medicine at Mount Sinai.
He previously worked as an Assistant Professor at Weill Cornell Medical College and an Associate Professor at New York University School of Medicine.
Dr. Sordillo has a graduate and doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from New York University, a graduate degree from New York Medical College, and an undergraduate degree from Columbia College (New York).
Aktive Positionen von Peter Sordillo
Unternehmen | Position | Beginn |
---|---|---|
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 |
Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Peter Sordillo
Unternehmen | Position | Ende |
---|---|---|
New York University School of Medicine | Corporate Officer/Principal | - |
Weill Cornell Medical College | Corporate Officer/Principal | - |
Ausbildung von Peter Sordillo
The Trustees of Columbia University in The City of New York | Doctorate Degree |
New York University | Graduate Degree |
New York Medical College | Graduate Degree |
Columbia College (New York) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |